We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · November 11, 2022

Efficacy of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

Journal of Clinical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations
J. Clin. Oncol 2022 Oct 26;[EPub Ahead of Print], PK Brastianos, EL Twohy, ER Gerstner, TJ Kaufmann, AJ Iafrate, J Lennerz, S Jeyapalan, DE Piccioni, V Monga, CE Fadul, D Schiff, JW Taylor, SA Chowdhary, C Bettegowda, G Ansstas, M De La Fuente, MD Anderson, N Shonka, D Damek, J Carrillo, LJ Kunschner-Ronan, R Chaudhary, KA Jaeckle, FM Senecal, T Kaley, T Morrison, AA Thomas, MR Welch, F Iwamoto, D Cachia, AL Cohen, S Vora, M Knopp, IF Dunn, P Kumthekar, J Sarkaria, S Geyer, XW Carrero, M Martinez-Lage, DP Cahill, PD Brown, C Giannini, S Santagata, FG Barker, E Galanis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Brain Cancer Center of Excellence

Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.

Further Reading